Search Results 1951-1960 of 21513 for platelets

1. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery - Mayo Clinic

   Platelets ≥ 100,000/μL; Total bilirubin ≤ upper limit of normal (ULN); Aspartate aminotransferase (AST) ≤ 3 times upper limit of normal (ULN); Creatinine ...

2. Study of Pomalidomide for Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma and Newly Diagnosed or Relapsed/Refractory Intraocular Lymphoma - Mayo Clinic

   Platelets (PLT) ≥ 100,000/uL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN the direct bilirubin must be ≤ 1.5 ...

3. A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   Platelet count < 150,000/mm3. Immunoglobulin G4 (IgG4) > 4 × ULN at screening; or evidence consistent with the diagnosis of IgG4-related sclerosing ...

4. Radiation Therapy and Docetaxel in Treating Patients with HPV-Related Oropharyngeal Cancer - Mayo Clinic

   Lymph node extracapsular extension. Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL; Direct bilirubin ...

5. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer - Mayo Clinic

   Platelet count >= 100,000/mm^3; Creatinine =< 1.5 x upper limit of normal (ULN) mg/dL OR calculated (calc.) creatinine clearance >= 60 mL/min; Bilirubin ...

6. A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis - Mayo Clinic

   Platelet count < 100 x109th/L; Underlying infection with C. difficile at screening visit; Pre-existing hepatic disease; Known non-alcoholic fatty liver disease ...

7. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

   Life expectancy ≥ 6 months; Hemoglobin ≥ 10.0 g/dL; Leukocytes ≥ 3,500/mm^3; ANC ≥ 1,500/mm^3; Platelet count ≥ 100,000/mm^3; Creatinine ≤ 1.5 times upper ...

8. A Study to Evaluate Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery - Mayo Clinic

   Bleeding disorder, treatment with warfarin, or platelet count < 50,000 /mm3. Active alcohol abuse or substance abuse (per investigator assessment). Current ...

9. Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients - Mayo Clinic

   Adequate hematologic function (ANC ≥ 1,500/μL, platelet count ≥ 100,000/μL, and hemoglobin ≥ 10.5 gm/dL) within 14 days prior to randomization. Total ...

10. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    Adequate hematological function: ANC ≥ 1000/mm3, platelets. 75,000/mm3, hemoglobin ≥ 9 g/dL. Transfusion and/or growth factor are allowed but counts must ...